-
1
-
-
33646405176
-
Recent advance in antiplatelet therapy: The mechanisms, evidence and approach to the problems
-
Horiuchi H. Recent advance in antiplatelet therapy: The mechanisms, evidence and approach to the problems. Ann Med 2006; 38: 162-172.
-
(2006)
Ann Med
, vol.38
, pp. 162-172
-
-
Horiuchi, H.1
-
2
-
-
38949119325
-
''Resistance'' and risk of cardiovascular morbidity: Systematic review and meta-analysis
-
Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR. Aspirin ''resistance'' and risk of cardiovascular morbidity: Systematic review and meta-analysis. BMJ 2008; 336: 195H-198H.
-
(2008)
BMJ
, vol.336
-
-
Krasopoulos, G.1
Brister, S.J.2
Beattie, W.S.3
Buchanan, M.R.4
-
3
-
-
1542708471
-
Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment
-
Chen WH, Lee PY, Ng W, Tse HF, Lau CP. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreat-ment. J Am Coll Cardiol 2004; 43: 1122-1126.
-
(2004)
J Am Coll Cardiol
, vol.43
, pp. 1122-1126
-
-
Chen, W.H.1
Lee, P.Y.2
Ng, W.3
Tse, H.F.4
Lau, C.P.5
-
4
-
-
0037046196
-
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events
-
Eikelboom JW, Hirsh J, Weitz JI, Johnston M, Yi Q, Yusuf S. Aspirin-resistant thromboxane biosynthesis and the risk of myo-cardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 2002; 105: 1650-1655.
-
(2002)
Circulation
, vol.105
, pp. 1650-1655
-
-
Eikelboom, J.W.1
Hirsh, J.2
Weitz, J.I.3
Johnston, M.4
Yi, Q.5
Yusuf, S.6
-
5
-
-
1542604069
-
Inhibition of platelet aggregation by aspirin progressively decreases in long term treated patients
-
Pulcinelli FM, Pignatelli P, Celestini A, Riondino S, Gazzaniga PP, Violi F. Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients. J Am Coll Cardiol 2004; 43: 979-984.
-
(2004)
J Am Coll Cardiol
, vol.43
, pp. 979-984
-
-
Pulcinelli, F.M.1
Pignatelli, P.2
Celestini, A.3
Riondino, S.4
Gazzaniga, P.P.5
Violi, F.6
-
6
-
-
0025804692
-
Persistent inhibition of platelet-function during long-term treatment with 75 mg acetylsalicylic-acid daily in men with unstable coronary-artery disease
-
Berglund U, Wallentin L. Persistent inhibition of platelet-function during long-term treatment with 75 mg acetylsalicylic-acid daily in men with unstable coronary-artery disease. Eur Heart J 1991; 12: 428-433.
-
(1991)
Eur Heart J
, vol.12
, pp. 428-433
-
-
Berglund, U.1
Wallentin, L.2
-
7
-
-
0011859824
-
Comparative effectiveness of adenosine analogues as inhibitors of blood-platelet aggregation and as vasodilators in man
-
Born GVR, Haslam RJ, Goldman M, Lowe RD. Comparative effectiveness of adenosine analogues as inhibitors of blood-platelet aggregation and as vasodilators in man. Nature 1965; 205: 678-680.
-
(1965)
Nature
, vol.205
, pp. 678-680
-
-
Born, G.V.R.1
Haslam, R.J.2
Goldman, M.3
Lowe, R.D.4
-
8
-
-
0035862593
-
Characterization of whole blood aggregation with a new type of aggregometer by a screen filtration pressure method
-
Ozeki Y, Sudo T, Toga K, Nagamura Y, Ito H, Ogawa T, et al. Characterization of whole blood aggregation with a new type of aggregometer by a screen filtration pressure method. Thromb Res 2001; 101: 65-72.
-
(2001)
Thromb Res
, vol.101
, pp. 65-72
-
-
Ozeki, Y.1
Sudo, T.2
Toga, K.3
Nagamura, Y.4
Ito, H.5
Ogawa, T.6
-
9
-
-
0015493362
-
Prostaglandin-e1 in platelet harvesting: In-vitro study
-
Shio H, Ramwell PW. Prostaglandin-e1 in platelet harvesting: In-vitro study. Science 1972; 175: 536-538.
-
(1972)
Science
, vol.175
, pp. 536-538
-
-
Shio, H.1
Ramwell, P.W.2
-
10
-
-
0013902965
-
Blood cell aggregation and screen filtration pressure
-
Swank RL, Davis E. Blood cell aggregation and screen filtration pressure. Circulation 1966; 33: 617-624.
-
(1966)
Circulation
, vol.33
, pp. 617-662
-
-
Swank, R.L.1
Davis, E.2
-
11
-
-
42649101332
-
Action of aspirin on whole blood-aggregation evaluated by the screen filtration pressure method
-
Tabuchi A, Taniguchi R, Takahashi K, Kondo H, Kawato M, Morimoto T, et al. Action of aspirin on whole blood-aggregation evaluated by the screen filtration pressure method. Circ J 2008; 72: 420-426.
-
(2008)
Circ J
, vol.72
, pp. 420-426
-
-
Tabuchi, A.1
Taniguchi, R.2
Takahashi, K.3
Kondo, H.4
Kawato, M.5
Morimoto, T.6
-
12
-
-
67649975510
-
On behalf of the J-PMS study group. Assessment of sirolimuseluting coronary stent implantation with aspirin plus low dose ticlopidine administration: One year results from CYPHER stent Japan Post Marketing Surveillance registry (J-PMS)
-
Ikari Y, Kotani J, Kozuma K, Kyo E, Nakamura M, Yokoi H, et al on behalf of the J-PMS study group. Assessment of sirolimus-eluting coronary stent implantation with aspirin plus low dose ticlopidine administration: One year results from CYPHER stent Japan Post Marketing Surveillance registry (J-PMS). Circ J 2009; 73: 1038-1044.
-
(2009)
Circ J
, vol.73
, pp. 1038-1044
-
-
Ikari, Y.1
Kotani, J.2
Kozuma, K.3
Kyo, E.4
Nakamura, M.5
Yokoi, H.6
-
13
-
-
33646761285
-
Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: Involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients
-
Ohmori T, Yatomi Y, Nonaka T, Kobayashi Y, Madoiwa S, Mimuro J, et al. Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: Involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients. J Thromb Haemost 2006; 4: 1271-1278.
-
(2006)
J Thromb Haemost
, vol.4
, pp. 1271-1278
-
-
Ohmori, T.1
Yatomi, Y.2
Nonaka, T.3
Kobayashi, Y.4
Madoiwa, S.5
Mimuro, J.6
-
14
-
-
34848889330
-
Exploratory aspirin resistance trial in healthy Japanese volunteers (J-ART) using platelet aggregation as a measure of thrombo-genicity
-
Fujiwara T, Ikeda M, Esumi K, Fujita TD, Kono M, Tokushige H, et al. Exploratory aspirin resistance trial in healthy Japanese volunteers (J-ART) using platelet aggregation as a measure of thrombo-genicity. Pharmacogenomics J 2007; 7: 395-403.
-
(2007)
Pharmacogenomics J
, vol.7
, pp. 395-403
-
-
Fujiwara, T.1
Ikeda, M.2
Esumi, K.3
Fujita, T.D.4
Kono, M.5
Tokushige, H.6
-
15
-
-
0036138569
-
Report of the committee on the classification and diagnostic criteria of diabetes mellitus
-
Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract 2002; 55: 65-85.
-
(2002)
Diabetes Res Clin Pract
, vol.55
, pp. 65-85
-
-
Kuzuya, T.1
Nakagawa, S.2
Satoh, J.3
Kanazawa, Y.4
Iwamoto, Y.5
Kobayashi, M.6
-
16
-
-
0037431745
-
Platelet responsiveness to aspirin in patients with hyperlipidaemia
-
Friend M, Vucenik I, Miller M. Platelet responsiveness to aspirin in patients with hyperlipidaemia. BMJ 2003; 326: 82-83.
-
(2003)
BMJ
, vol.326
, pp. 82-83
-
-
Friend, M.1
Vucenik, I.2
Miller, M.3
-
17
-
-
2042504400
-
Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicyclic acid (aspirin): Its relation to metabolic control
-
Watala C, Golanski J, Pluta J, Boncier M, Rozalski M, Luzak B, et al. Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicyclic acid (aspirin): Its relation to metabolic control. Thromb Res 2004; 113: 101-113.
-
(2004)
Thromb Res
, vol.113
, pp. 101-113
-
-
Watala, C.1
Golanski, J.2
Pluta, J.3
Boncier, M.4
Rozalski, M.5
Luzak, B.6
-
18
-
-
0028828489
-
Cigarette-smoking acutely increases platelet thrombus formation in patients with coronaryartery disease taking aspirin
-
Hung J, Lam JYT, Lacoste L, Letchacovski G. Cigarette-smoking acutely increases platelet thrombus formation in patients with coronaryartery disease taking aspirin. Circulation 1995; 92: 2432-2436.
-
(1995)
Circulation
, vol.92
, pp. 2432-2436
-
-
Hung, J.1
Lam, J.Y.T.2
Lacoste, L.3
Letchacovski, G.4
-
19
-
-
39849088945
-
Relationship between the serum scd40l level and aspirin resistant platelet aggregation in patients with stable coronary artery disease
-
Pamukcu B, Oflaz H, Onur L, Midilli K, Yilmaz G, Yilmaz E, et al. Relationship between the serum scd40l level and aspirin-resistant platelet aggregation in patients with stable coronary artery disease. Circ J 2008; 72: 61-66.
-
(2008)
Circ J
, vol.72
, pp. 61-66
-
-
Pamukcu, B.1
Oflaz, H.2
Onur, L.3
Midilli, K.4
Yilmaz, G.5
Yilmaz, E.6
-
20
-
-
0035421783
-
Profile and prevalence of aspirin resistance in patients with cardiovascular disease
-
Gum PA, Kottke-Marchant K, Poggio EC, Gurm H, Welsh PA, Brooks L, et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 2001; 88: 230-235.
-
(2001)
Am J Cardiol
, vol.88
, pp. 230-235
-
-
Gum, P.A.1
Kottke-Marchant, K.2
Poggio, E.C.3
Gurm, H.4
Welsh, P.A.5
Brooks, L.6
-
21
-
-
0042416748
-
Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs
-
Kurth T, Glynn RJ, Walker AM, Chan KA, Buring JE, Hennekens CH, et al. Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs. Circulation 2003; 108:1191-1195.
-
(2003)
Circulation
, vol.108
, pp. 1191-1195
-
-
Kurth, T.1
Glynn, R.J.2
Walker, A.M.3
Chan, K.A.4
Buring, J.E.5
Hennekens, C.H.6
-
22
-
-
12844269195
-
Biological assessment of aspirin efficacy on healthy individuals: Heterogeneous Response or Aspirin Failure?
-
Gonzalez-Conejero R, Rivera J, Corral J, Acuna C, Guerrero JA, Vicente V. Biological assessment of aspirin efficacy on healthy individuals: Heterogeneous response or aspirin failure? Stroke 2005;36: 276-280.
-
(2005)
Stroke
, vol.36
, pp. 276-280
-
-
Gonzalez-Conejero, R.1
Rivera, J.2
Corral, J.3
Acuna, C.4
Guerrero, J.A.5
Vicente, V.6
-
23
-
-
0032884270
-
Antiplatelet effect of amlo-dipine: A possible mechanism through a nitric oxide, mediated process
-
Chou TC, Li CY, Yen MH, Ding YA. Antiplatelet effect of amlo-dipine: A possible mechanism through a nitric oxide, mediated process. Biochem Pharmacol 1999; 58: 1657-1663.
-
(1999)
Biochem Pharmacol
, vol.58
, pp. 1657-1663
-
-
Chou, T.C.1
Li, C.Y.2
Yen, M.H.3
Ding, Y.A.4
-
24
-
-
0028820968
-
Platelet aggregability in-vivo is attenuated by verapamil but not by metoprolol in patient with stable angina-pectoris
-
Wallen NH, Held C, Rehnqvist N, Hjemdahl P. Platelet aggregability in-vivo is attenuated by verapamil but not by metoprolol in patient with stable angina-pectoris. Am J Cardiol 1995; 75: 1-6.
-
(1995)
Am J Cardiol
, vol.75
, pp. 1-6
-
-
Wallen, N.H.1
Held, C.2
Rehnqvist, N.3
Hjemdahl, P.4
-
25
-
-
9844224482
-
Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty
-
Mueller MR, Salat A, Stangl P, Murabito M, Pulaki S, Boehm D, et al. Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty. Thromb Haemost 1997; 78: 1003-1007.
-
(1997)
Thromb Haemost
, vol.78
, pp. 1003-1007
-
-
Mueller, M.R.1
Salat, A.2
Stangl, P.3
Murabito, M.4
Pulaki, S.5
Boehm, D.6
-
26
-
-
0029127945
-
Aspirin therapy: Optimized platelet inhibition with different loading and maintenance doses
-
Buerke M, Pittroff W, Meyer J, Darius H. Aspirin therapy: Optimized platelet inhibition with different loading and maintenance doses. Am Heart J 1995; 130: 465-472.
-
(1995)
Am Heart J
, vol.130
, pp. 465-472
-
-
Buerke, M.1
Pittroff, W.2
Meyer, J.3
Darius, H.4
-
27
-
-
0043095307
-
Timing of antiplatelet effect after oral aspirin administration in patients with sympathetic excitement
-
Nishiyama A, Niikawa O, Mohri H, Tsushima M. Timing of antiplatelet effect after oral aspirin administration in patients with sympathetic excitement. Circ J 2003; 67: 697-700.
-
(2003)
Circ J
, vol.67
, pp. 697-700
-
-
Nishiyama, A.1
Niikawa, O.2
Mohri, H.3
Tsushima, M.4
|